● Recruiting

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

Condition: Excessive Sleepiness · Shift-work Disorder · Sponsor: Axsome Therapeutics, Inc.

PhasePhase 3

Planned participants520

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

SUSTAIN (Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with excessive sleepiness associated with shift work disorder (SWD).

This description comes directly from the study's public registry record.

Talk to the study team

Study Director · 212-332-5061 · sol-swd-301@axsome.com

Always discuss trial participation with your own doctor first.

Locations (49)

Clinical Research Site	Auburn, Alabama, United States	Recruiting
Clinical Research Site	Cullman, Alabama, United States	Recruiting
Clinical Research Site	Chandler, Arizona, United States	Recruiting
Clinical Research Site	Tucson, Arizona, United States	Withdrawn
Clinical Research Site	Little Rock, Arkansas, United States	Recruiting
Clinical Research Site	Anaheim, California, United States	Recruiting
Clinical Research Site	Cerritos, California, United States	Recruiting
Clinical Research Site	Chula Vista, California, United States	Terminated
Clinical Research Site	Huntington Beach, California, United States	Recruiting
Clinical Research Site	Long Beach, California, United States	Recruiting
Clinical Research Site	Santa Ana, California, United States	Recruiting
Clinical Research Site	Colorado Springs, Colorado, United States	Recruiting

+ 37 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06568367